Literature DB >> 16380498

Increased renal arterial resistance predicts the course of renal function in type 2 diabetes with microalbuminuria.

Romano Nosadini1, Mario Velussi, Enrico Brocco, Cataldo Abaterusso, Andrea Carraro, Francesco Piarulli, Giuseppe Morgia, Andrea Satta, Rossana Faedda, Avinash Abhyankar, Holgher Luthman, Giancarlo Tonolo.   

Abstract

Type 2 diabetic patients often die because of end-stage renal failure, but no definitive reliable factor predicting long-term renal outcome has been identified. We tested whether a renal arterial resistance index (R/I) > or =80, using Doppler ultrasound technique, was predictive of worsening renal function. The primary end points of the study were 1) the course of glomerular filtration rate (GFR) and 2) the albumin excretion rate in 157 microalbuminuric, hypertensive, type 2 diabetic patients after a 7.8-year follow-up period (range 7.1-9.2). Kaplan-Meier curves for the primary end point (decrease of GFR > or = -3.0 ml/min per 1.73 m(2) per year) was two to three times more frequently observed in patients with R/I > or =80. Four- to fivefold fewer patients showed a regression to normoalbuminuria during the follow-up period from baseline microalbuminuria in the cohort with R/I > or =80. Overt proteinuria did develop in 24% of patients with R/I > or =80 and in 5% of patients with R/I <80 (P < 0.01). In conclusion, intrarenal arterial resistance appears to play a nontrivial role in deteriorating renal function in type 2 diabetic patients. R/I is a noninvasive diagnostic procedure, which strongly predicts the outcome of renal function in type 2 diabetic patients, even when GFR patterns are still normal.

Entities:  

Mesh:

Year:  2006        PMID: 16380498

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

1.  Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography.

Authors:  Peifeng Dai; Junhua Wang; Lin Lin; Yanyan Zhang; Zhengping Wang
Journal:  Exp Ther Med       Date:  2015-06-22       Impact factor: 2.447

2.  Altered oscillation of Doppler-derived renal and renal interlobar venous flow velocities in hypertensive and diabetic patients.

Authors:  Yusuke Kudo; Taisei Mikami; Mutsumi Nishida; Kazunori Okada; Sanae Kaga; Nobuo Masauzi; Satomi Omotehara; Hitoshi Shibuya; Kaoru Kahata; Chikara Shimizu
Journal:  J Med Ultrason (2001)       Date:  2017-02-01       Impact factor: 1.314

Review 3.  Renal intraparenchymal resistive index: the ultrasonographic answer to many clinical questions.

Authors:  Pierpaolo Di Nicolò; Antonio Granata
Journal:  J Nephrol       Date:  2018-12-11       Impact factor: 3.902

4.  Comparison between the effects of hydrochlorothiazide and indapamide on the kidney in hypertensive patients inadequately controlled with losartan.

Authors:  S Wang; J Li; X Zhou; K Liu; X Zhang; Q Meng; R Shi; D Shi; X Chen
Journal:  J Hum Hypertens       Date:  2017-07-13       Impact factor: 3.012

5.  Cerebral microvascular disease predicts renal failure in type 2 diabetes.

Authors:  Takashi Uzu; Yasuo Kida; Nobuo Shirahashi; Tamaki Harada; Atsushi Yamauchi; Makoto Nomura; Keiji Isshiki; Shin-Ichi Araki; Toshiro Sugimoto; Daisuke Koya; Masakazu Haneda; Atsunori Kashiwagi; Ryuichi Kikkawa
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

6.  External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters.

Authors:  Claudia S Lennartz; John William Pickering; Sarah Seiler-Mußler; Lucie Bauer; Kathrin Untersteller; Insa E Emrich; Adam M Zawada; Jörg Radermacher; Navdeep Tangri; Danilo Fliser; Gunnar H Heine
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-19       Impact factor: 8.237

7.  Associations of renal vascular resistance with albuminuria and other macroangiopathy in type 2 diabetic patients.

Authors:  Kumiko Hamano; Ai Nitta; Takayasu Ohtake; Shuzo Kobayashi
Journal:  Diabetes Care       Date:  2008-06-19       Impact factor: 19.112

8.  Renal hyperfiltration and arterial stiffness in humans with uncomplicated type 1 diabetes.

Authors:  David Z I Cherney; Etienne B Sochett; Vesta Lai; Maria G Dekker; Cameron Slorach; James W Scholey; Timothy J Bradley
Journal:  Diabetes Care       Date:  2010-06-28       Impact factor: 19.112

9.  Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance.

Authors:  Utpal Sen; Walter E Rodriguez; Neetu Tyagi; Munish Kumar; Soumi Kundu; Suresh C Tyagi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-09       Impact factor: 4.310

Review 10.  The internist and the renal resistive index: truths and doubts.

Authors:  Maria Boddi; Fabrizia Natucci; Elisa Ciani
Journal:  Intern Emerg Med       Date:  2015-09-04       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.